SEC Comment Letter for TANDEM DIABETES CARE INC (TNDM) (CIK 0001438133) (TNDM) — Jan 24, 2018
TANDEM DIABETES CARE INC (TNDM) (CIK 0001438133)
Date: Jan. 24, 2018 · CIK: 0001438133 · Accession: 0000000000-18-002626
AI Filing Summary & Sentiment
Reasoning
Letter
Mail Stop 3030 January 2 4, 2018 Via E -mail Kim D. Blickenstaff President and Chief Executive Officer Tandem Diabetes Care, Inc. 11075 Roselle Street San Diego, California 92121
Re: Tandem Diabetes Care, Inc. Registration Statement on Form S-1 Filed January 16, 2018 File No. 333 -222553
Dear M r. Blickenstaff :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tom Jones at (202) 551 -3602 with any questions.
Sincerely,
/s/ Tom Jones for
Show Raw Text
Mail Stop 3030
January 2 4, 2018
Via E -mail
Kim D. Blickenstaff
President and Chief Executive Officer
Tandem Diabetes Care, Inc.
11075 Roselle Street
San Diego, California 92121
Re: Tandem Diabetes Care, Inc.
Registration Statement on Form S-1
Filed January 16, 2018
File No. 333 -222553
Dear M r. Blickenstaff :
This is to advise you that we have not reviewed and will not review your registration
statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tom Jones at (202) 551 -3602 with any questions.
Sincerely,
/s/ Tom Jones for
Amanda Ravitz
Assistant Director
Office of Electronics and Machinery
cc: Bruce Feuchter , Esq.